Gov. Bev Perdue today announced that Biotage LLC, a Swedish company that develops and manufactures instruments and consumables for pharmaceutical research, will relocate its United States headquarters to Charlotte. The company plans to invest in facility upgrades and create 21 new jobs in Mecklenburg County.
“North Carolina is known globally as a strategic location for tapping into the North American market,” Perdue said. “Our top-rated business climate and highly skilled workforce continue to attract global companies looking to invest and expand.”
Biotage is a leading supplier of tools and technology for medicinal and analytical chemistry and process development. The company, headquartered in Sweden, has offices in the U.S., the United Kingdom and Japan and employs nearly 270 workers worldwide.
The company is planning to move its U.S. headquarters from Virginia to North Carolina. Operations in Charlotte will include general administration, marketing and sales, and lab work for applications development, light manufacturing and distribution.
“We are excited about the relocation of our North American headquarters to Charlotte, as the area provides access to a major international airport, which is very important as an international company,” said Scott Carr, president, Biotage LLC. “Charlotte also offers a strong labor pool, increased options for business-service providers and the potential for reduced operating costs.”
Partners in the project include the Charlotte Chamber, Charlotte Regional Partnership, N.C. Biotechnology Center and N.C. Department of Commerce. For more information on Biotage, please visit the company’s Web site at: www.biotage.com.